Glecaprevir/Pibrentasvir in HCV With Psychiatric Disorders

08:00 EDT 9 Sep 2019 | Medscape

This study evaluated the impact of comorbid psychiatric disorders on the treatment adherence, efficacy, and safety of glecaprevir/pibrentasvir in patients with chronic HCV.
Journal of Viral Hepatitis

Original Article: Glecaprevir/Pibrentasvir in HCV With Psychiatric Disorders


More From BioPortfolio on "Glecaprevir/Pibrentasvir in HCV With Psychiatric Disorders"

Quick Search

Relevant Topics

Psychiatry is the study of mental disorders and their diagnosis, management and prevention.  Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...

Hepatitis (plural hepatitides) is a medical condition defined by the inflammation of the liver and characterized by the presence of inflammatory cells in the tissue of the organ. The condition can be self-limiting (healing on its own) or can progress to ...